DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Rastogi P, Buyse ME, Swain SM et al.
Concurrent bevacizumab with a sequential regimen of doxorubicin and
cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy
for HER2- locally advanced breast cancer: a phase II trial of the NSABP
Foundation Research Group.
Clin Breast Cancer 2011;
11: 228-234
Access:
We do not assume any responsibility for the contents of the web pages of other providers.